# "Prime-Boost" Vaccine Schedule for Prevention of HIV Infection

> **NCT00109629** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 40 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** VRC-HIVDNA016-00-VP
- **DRUG:** VRC-HIVADV014-00

## Key facts

- **NCT ID:** NCT00109629
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04-26
- **Primary completion:** —
- **Final completion:** 2008-01-22
- **Target enrollment:** 40 (—)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00109629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00109629, ""Prime-Boost" Vaccine Schedule for Prevention of HIV Infection". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00109629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*